These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34678659)

  • 1. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.
    Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY
    Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study.
    Gondim RNDG; de Arruda EAG; Neto RDJP; Medeiros MS; Quirino-Filho J; Clementino MA; Magalhães LMVC; Cavalcante KF; Viana VAF; Mello LP; Carlos LMB; Havt A; Lima AAM
    J Med Virol; 2023 Aug; 95(8):e29044. PubMed ID: 37605987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
    J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.
    van der Mescht MA; Steel HC; de Beer Z; Abdullah F; Ueckermann V; Anderson R; Rossouw TM
    Front Immunol; 2023; 14():1235914. PubMed ID: 37646024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.
    Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A
    Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
    Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
    Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
    Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.
    Devlin L; Gombolay GY
    J Neurol; 2023 Nov; 270(11):5155-5161. PubMed ID: 37581633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
    Reinhold D; Farztdinov V; Yan Y; Meisel C; Sadlowski H; Kühn J; Perschel FH; Endres M; Düzel E; Vielhaber S; Guttek K; Goihl A; Venø M; Teegen B; Stöcker W; Stubbemann P; Kurth F; Sander LE; Ralser M; Otto C; Streit S; Jarius S; Ruprecht K; Radbruch H; Kjems J; Mülleder M; Heppner F; Körtvelyessy P
    J Neuroinflammation; 2023 Feb; 20(1):30. PubMed ID: 36759861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019.
    Mohammadhosayni M; Sadat Mohammadi F; Ezzatifar F; Mahdavi Gorabi A; Khosrojerdi A; Aslani S; Hemmatzadeh M; Yazdani S; Arabi M; Marofi F; Jadidi-Niaragh F; Shomali N; Mohammadi H
    Int Immunopharmacol; 2021 Nov; 100():108076. PubMed ID: 34450402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
    Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
    J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.